FLCGX | JVMRX | FLCGX / JVMRX | |
Total Expense Ratio | 1.77 | 0.75 | 236% |
Annual Report Gross Expense Ratio | 1.77 | 0.76 | 233% |
Fund Existence | 40 years | 14 years | - |
Gain YTD | -0.668 | -0.965 | 69% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 35.3M | 20.9B | 0% |
Annual Yield % from dividends | 0.99 | 0.96 | 103% |
Returns for 1 year | -10.24 | -7.52 | 136% |
Returns for 3 years | 3.86 | 7.37 | 52% |
Returns for 5 years | 37.10 | 55.51 | 67% |
Returns for 10 years | 2.87 | 34.25 | 8% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RGLFX | 24.45 | 0.05 | +0.20% |
American Funds Global Insight R-5 | |||
SSLCX | 49.34 | -0.02 | -0.04% |
DWS Small Cap Core S | |||
MOPAX | 23.01 | -0.10 | -0.43% |
NYLI WMC Small Companies Class A | |||
FSSAX | 23.74 | -0.16 | -0.67% |
Franklin Small Cap Growth Adv | |||
BIPSX | 17.94 | -0.60 | -3.24% |
ProFunds Biotechnology UltraSector Svc |